References
- Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, et al. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 2001; 19: 376–388
- Bacha P, Williams D P, Waters C, Williams J M, Murphy J R, Strom T B, et al. Interleukin-2 receptor-targeted cytotoxicity. J Exp Med 1988; 167: 612–622
- Nasu K, Said J, Vonderheid E, Olerud J, Sako D, Kadin M, et al. Immunopathology of cutaneous T-cell lymphomas. Am J Pathol 1985; 119: 436–447
- Ruddle J B, Harper C A, Honemann D, Seymour J F, Prince H M. A denileukin diftitox (Ontak) associated retinopathy?. Br J Ophthalmol 2006; 90: 1070–1071
- Willemze R, Jaffe E S, Burg G, Cerroni L, Berti E, Swerdlow S H, Ralfkiaer E, Chimenti S, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–3785
- LeMaistre C F, Kuzel T M, Saleh M N, Platanias L C, Schwartz G. Phase I trial of a ligand fusion-protein (DAB389 IL-2) in lymphomas expressing the receptor for interleukin-2. Blood 1998; 91: 399–405
- Saleh M N, LeMaistre C F, Kuzel T M, Foss F, Platanias L C, Schwartz G, et al. Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides. J Am Acad Dermatol 1998; 39: 63–73
- Roth S, Gillesberg I. Injuries to the visual system and other sense organs. Anesthesia and Perioperative Complications, 2nd ed, J L Benumof, L J Saidman. Mosby, St. Louis, MO 1999; 377–408
- Hayreh S S, Podhajsky P, Zimmerman M B. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 1999; 213: 76–96
- Sadda S R, Nee M, Miller N R, Biousse V, Newman N J, Kouzis A, et al. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthal 2001; 132: 743–750
- Chang S H, Miller N R. The incidence of vision loss due to perioperative ischemic optic neuropathy associated with spine surgery. Spine 2005; 30: 1299–1302
- Remigio D, Wertenbaker C. Post-operative bilateral vision loss. Surv Opthalmol 2000; 44: 426–432
- Buono L M, Foroozan R. Perioperative posterior ischemic optic neuropathy: review of the literature. Surv Ophthalmol 2005; 50: 15–26
- Isayama Y, Takahashi T, Inoue M, Jimura T. Posterior ischemic optic neuropathy. III. Clinical diagnosis. Ophthalmologica 1983; 187: 141–147
- Lee A G. Reversible loss of vision due to posterior ischemic optic neuropathy. Can J Ophthalmol 1995; 30: 327–329